261 related articles for article (PubMed ID: 32811613)
1. Transcranial Pulsed Ultrasound with Alteplase Intravenous Thrombolysis for Vascular Recanalisation in Acute Ischemic Stroke.
Chen Z; Zhang J
J Coll Physicians Surg Pak; 2020 Jul; 30(7):765-767. PubMed ID: 32811613
[TBL] [Abstract][Full Text] [Related]
2. Effect of admission serum glucose on the clinical prognosis of patients with acute ischemic stroke receiving alteplase intravenous thrombolysis.
Huang P; Yi X
Int J Immunopathol Pharmacol; 2023; 37():3946320231204597. PubMed ID: 37771034
[No Abstract] [Full Text] [Related]
3. Efficacy of Tirofiban Administered at Different Time Points after Intravenous Thrombolytic Therapy with Alteplase in Patients with Acute Ischemic Stroke.
Liu J; Shi Q; Sun Y; He J; Yang B; Zhang C; Guo R
J Stroke Cerebrovasc Dis; 2019 Apr; 28(4):1126-1132. PubMed ID: 30655038
[TBL] [Abstract][Full Text] [Related]
4. Predictive role of admission serum glucose, baseline NIHSS score, and fibrinogen on hemorrhagic transformation after intravenous thrombolysis with alteplase in acute ischemic stroke.
Huang P; Yi XY
Eur Rev Med Pharmacol Sci; 2023 Oct; 27(20):9710-9720. PubMed ID: 37916334
[TBL] [Abstract][Full Text] [Related]
5. Multicenter Study of Intravenous Recombinant Tissue Plasminogen Activator Infusion around Hiroshima, Japan: The Hiroshima Acute Stroke Retrospective and Prospective Registry Study.
Aoki S; Hosomi N; Sueda Y; Kono T; Takamatsu K; Ohyama H; Torii T; Kitamura T; Nomura E; Noda K; Ohtsuki T; Matsumoto M;
J Stroke Cerebrovasc Dis; 2015 Dec; 24(12):2747-53. PubMed ID: 26360972
[TBL] [Abstract][Full Text] [Related]
6. Clinical Course of Acute Ischemic Stroke Due to Medium Vessel Occlusion With and Without Intravenous Alteplase Treatment.
Ospel JM; Menon BK; Demchuk AM; Almekhlafi MA; Kashani N; Mayank A; Fainardi E; Rubiera M; Khaw A; Shankar JJ; Dowlatshahi D; Puig J; Sohn SI; Ahn SH; Poppe A; Calleja A; Hill MD; Goyal M
Stroke; 2020 Nov; 51(11):3232-3240. PubMed ID: 33070714
[TBL] [Abstract][Full Text] [Related]
7. Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke.
Clark WM; Wissman S; Albers GW; Jhamandas JH; Madden KP; Hamilton S
JAMA; 1999 Dec; 282(21):2019-26. PubMed ID: 10591384
[TBL] [Abstract][Full Text] [Related]
8. Safety and efficacy of sonothrombolysis for acute ischaemic stroke: a multicentre, double-blind, phase 3, randomised controlled trial.
Alexandrov AV; Köhrmann M; Soinne L; Tsivgoulis G; Barreto AD; Demchuk AM; Sharma VK; Mikulik R; Muir KW; Brandt G; Alleman J; Grotta JC; Levi CR; Molina CA; Saqqur M; Mavridis D; Psaltopoulou T; Vosko M; Fiebach JB; Mandava P; Kent TA; Alexandrov AW; Schellinger PD;
Lancet Neurol; 2019 Apr; 18(4):338-347. PubMed ID: 30878103
[TBL] [Abstract][Full Text] [Related]
9. Thrombolysis outcomes according to arterial characteristics of acute ischemic stroke by alteplase dose and blood pressure target.
Zhou Z; Xia C; Mair G; Delcourt C; Yoshimura S; Liu X; Chen Z; Malavera A; Carcel C; Chen X; Wang X; Al-Shahi Salman R; Robinson TG; Lindley RI; Chalmers J; Wardlaw JM; Parsons MW; Demchuk AM; Anderson CS
Int J Stroke; 2022 Jun; 17(5):566-575. PubMed ID: 34096413
[TBL] [Abstract][Full Text] [Related]
10. Influence of Renal Impairment on Outcome for Thrombolysis-Treated Acute Ischemic Stroke: ENCHANTED (Enhanced Control of Hypertension and Thrombolysis Stroke Study) Post Hoc Analysis.
Carr SJ; Wang X; Olavarria VV; Lavados PM; Rodriguez JA; Kim JS; Lee TH; Lindley RI; Pontes-Neto OM; Ricci S; Sato S; Sharma VK; Woodward M; Chalmers J; Anderson CS; Robinson TG;
Stroke; 2017 Sep; 48(9):2605-2609. PubMed ID: 28739832
[TBL] [Abstract][Full Text] [Related]
11. Intravenous thrombolysis with neuroprotective therapy by edaravone for ischemic stroke patients older than 80 years of age.
Kono S; Deguchi K; Morimoto N; Kurata T; Yamashita T; Ikeda Y; Narai H; Manabe Y; Takao Y; Kawada S; Kashihara K; Takehisa Y; Inoue S; Kiriyama H; Abe K
J Stroke Cerebrovasc Dis; 2013 Oct; 22(7):1175-83. PubMed ID: 23507462
[TBL] [Abstract][Full Text] [Related]
12. MRI-Guided Thrombolysis for Stroke with Unknown Time of Onset.
Thomalla G; Simonsen CZ; Boutitie F; Andersen G; Berthezene Y; Cheng B; Cheripelli B; Cho TH; Fazekas F; Fiehler J; Ford I; Galinovic I; Gellissen S; Golsari A; Gregori J; Günther M; Guibernau J; Häusler KG; Hennerici M; Kemmling A; Marstrand J; Modrau B; Neeb L; Perez de la Ossa N; Puig J; Ringleb P; Roy P; Scheel E; Schonewille W; Serena J; Sunaert S; Villringer K; Wouters A; Thijs V; Ebinger M; Endres M; Fiebach JB; Lemmens R; Muir KW; Nighoghossian N; Pedraza S; Gerloff C;
N Engl J Med; 2018 Aug; 379(7):611-622. PubMed ID: 29766770
[TBL] [Abstract][Full Text] [Related]
13. Early Recanalization With Alteplase in Stroke Because of Large Vessel Occlusion in the ESCAPE Trial.
Ospel JM; Singh N; Almekhlafi MA; Menon BK; Butt A; Poppe AY; Jadhav A; Silver FL; Shah R; Dowlatshahi D; O'Hare AM; Demchuk AM; Goyal M; Hill MD
Stroke; 2021 Jan; 52(1):304-307. PubMed ID: 33213288
[TBL] [Abstract][Full Text] [Related]
14. A pragmatic approach to sonothrombolysis in acute ischaemic stroke: the Norwegian randomised controlled sonothrombolysis in acute stroke study (NOR-SASS).
Nacu A; Kvistad CE; Logallo N; Naess H; Waje-Andreassen U; Aamodt AH; Solhoff R; Lund C; Tobro H; Rønning OM; Salvesen R; Idicula TT; Thomassen L
BMC Neurol; 2015 Jul; 15():110. PubMed ID: 26162826
[TBL] [Abstract][Full Text] [Related]
15. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators.
Hacke W; Kaste M; Fieschi C; von Kummer R; Davalos A; Meier D; Larrue V; Bluhmki E; Davis S; Donnan G; Schneider D; Diez-Tejedor E; Trouillas P
Lancet; 1998 Oct; 352(9136):1245-51. PubMed ID: 9788453
[TBL] [Abstract][Full Text] [Related]
16. Polypharmacy, functional outcome and treatment effect of intravenous alteplase for acute ischaemic stroke.
Jensen M; Boutitie F; Cheng B; Cho TH; Ebinger M; Endres M; Fiebach JB; Fiehler J; Ford I; Galinovic I; Königsberg A; Puig J; Roy P; Wouters A; Thijs V; Lemmens R; Muir KW; Nighoghossian N; Pedraza S; Simonsen CZ; Gerloff C; Thomalla G
Eur J Neurol; 2021 Feb; 28(2):532-539. PubMed ID: 33015924
[TBL] [Abstract][Full Text] [Related]
17. Determinants of 1-Year Unfavorable Outcomes of Intravenous Alteplase Thrombolysis for Acute Ischemic Stroke.
Zhai M; Yang J; Cao X; Li Y; Xu H; Wang Y
Clin Appl Thromb Hemost; 2023; 29():10760296231187616. PubMed ID: 37461226
[TBL] [Abstract][Full Text] [Related]
18. Safety and Preliminary Efficacy of Early Tirofiban Treatment After Alteplase in Acute Ischemic Stroke Patients.
Li W; Lin L; Zhang M; Wu Y; Liu C; Li X; Huang S; Liang C; Wang Y; Chen J; Feng W
Stroke; 2016 Oct; 47(10):2649-51. PubMed ID: 27608821
[TBL] [Abstract][Full Text] [Related]
19. Safety and Efficacy of Intravenous Low-Dose Alteplase in Relative Contraindication Patients with Acute Ischemic Stroke.
Ohta T; Okada K; Fukuda M; Masahira N; Matsuoka T; Tsuno T; Takemura M
J Stroke Cerebrovasc Dis; 2018 Jul; 27(7):1844-1851. PubMed ID: 29555402
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of fingolimod combined with alteplase in acute ischemic stroke and rehabilitation nursing.
Liantao Z; Jing Z; Lingling L; Hua L
Pak J Pharm Sci; 2019 Jan; 32(1(Special)):413-419. PubMed ID: 30852478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
